Clinical Trial Update: Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intra-nasal sufentanil for analgesia in adults with vaso-occlusive crisis due to sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Crisis
• Sickle Cell Disease
• Vaso-occlusive Crisis

Drugs mentioned

• Sufentanil (sufentanil)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Sickle Cell Crisis | Phase 3 | Status: UNKNOWN